Chiral covalent organic framework incorporated organic polymer monolithic capillary column for enantioseparations

Study of the Enantioselectivity and Recognition Mechanism of Allyl-β-CD Modified Organic Polymer Monolithic Capillary Column

Allyl-β-CD was synthesized and used as the chiral functional monomer to prepare chiral organic polymer monolithic columns in capillary HPLC. First, the enantioselectivity of the prepared allyl-β-CD modified organic polymer monolithic capillary columns was investigated. Then, the influences of enantioseparation conditions of chiral drugs were further explored. Finally, the recognition mechanism was studied by molecular docking with AutoDock. Complete enantioseparations of four chiral drugs as well as partial enantioseparations of eight chiral drugs have been achieved. Results showed that the RSD values for run-to-run, day-to-day, and column-to-column variations ranged from 1.2% to 4.6%, 1.4% to 4.7%, and 2.0% to 6.1%, respectively. The enantioselectivity factor rather than resolution is correlated with the binding free energy difference between enantiomers with allyl-β-CD. Furthermore, the abundant ether bonds, hydroxyl groups, and hydrophobic cavities in cyclodextrin are responsible for the enantioseparation ability of the chiral monolithic capillary columns.

A minireview on covalent organic frameworks as stationary phases in chromatography

Advances in the design of novel porous materials open new avenues for the development of chromatographic solid stationary phases. Covalent organic frameworks (COFs) are promising candidates in this context due to their remarkable structural versatility and exceptional chemical and textural properties. In this minireview, we summarize the main strategies followed in recent years to apply these materials as stationary phases for chromatographic separations. We also comment on the perspectives of this new research field and potential directions to expand the applicability and implementation of COF stationary phases in analytical systems.

High-Enantioselectivity Adsorption Separation of Racemic Mandelic Acid and Methyl Mandelate by Robust Chiral UiO-68-Type Zr-MOFs

Mandelic acid and its analogues are highly valuable medical intermediates and play an important role in the pharmaceutical industry, biochemistry, and life sciences. Therefore, effective enantioselective recognition and separation of mandelic acid are of great significance. In this study, two of our recently reported chiral amine-alcohol-functionalized UiO-68-type Zr-HMOFs 1 and 3 with high chemical stability, abundant binding sites, and large chiral pores were selected as chiral selectors for the enantioselective separation of mandelic acid (MA), methyl mandelate (MM), and other chiral molecules containing only one phenyl. Materials 1 and 3 exhibited excellent enantioselective separation performance for MA and MM. Especially for the separation of racemate MA, the enantiomeric excess values reached 97.3 and 98.9%, which are the highest reported values so far. Experimental and density functional theory (DFT) computational results demonstrated that the introduction of additional phenyls on the chiral amine alcohol pendants in 3 had somewhat impact on the enantioselective adsorption and separation of MA or MM compared with 1, but it was not significant. Further research on the enantioselective separation of those chiral adsorbates containing only one phenyl by material 1 indicated the crucial role of the groups directly bonded to the chiral carbons of the adsorbates in the selective separation of enantiomers, especially showing higher enantioselectivity for the adsorbates with two hydrogen-bonding groups directly bonded to its chiral carbon.

Preparation of chiral monoliths with new modulation of the monolith surface chemistry for the enantioseparation of chiral drugs by nano-liquid chromatography

Here, we report the preparation and application of two new chiral monoliths for the enantioseparation of chiral drugs in nano-LC. Using 3‑chloro-2-hydroxypropylmethacrylate (HPMA-Cl, 2) as a precursor monomer, two different chiral monomers namely, Nα-Boc-Lys-HPMA (3A) and Nα-Fmoc-Lys-HPMA (3B) were synthesized and used for the preparation of chiral polymer monoliths. The first monolithic column (referred to as monolith I) was prepared by an in-situ polymerization of Nα-Boc-Lys-HPMA as the chiral monomer and ethylene dimethacrylate while the second monolithic column (referred to as monolith II) was prepared by an in-situ polymerization of Nα-Fmoc-Lys-HPMA as the chiral monomer and ethylene dimethacrylate as the crosslinker. Methanol and 1-propanol were used as the porogenic solvents. The prepared chiral monoliths were investigated for the enantioseparation of chiral drugs, including β-blockers (e.g., atenolol, propranolol, metoprolol) and anti-inflammatory drugs (e.g., ketoprofen, ibuprofen, flurbiprofen, naproxen, etodolac). The enantioseparation could be achieved via the formation of π-π interactions on the aromate-rich and aromate-poor chiral molecules while enantioseparation mechanism of chiral drugs included mostly π-π interactions and hydrogen bonding. Monolith II showed better enantioselectivity than Monolith I and the resolution values up to 2.12 were successfully achieved.